Donate

Industry News

Baxter Voluntary Recall

July 28, 2011

Notice: Baxter is voluntarily recalling one (1) lot of RECOMBINATE [Antihemophilic Factor (Recombinant)], product code 1501594, NDC Number 0944-2833-10, lot number TRA09834AB, with an expiry date of January 28, 2012. This action is being taken as a precautionary measure after a retrospective review of manufacturing processes revealed a potential breach in aseptic processing may have […]

BAXTER PRESENTS PRECLINICAL DATA AT ISTH ON ITS INVESTIGATIONAL COMPOUND BAX 499 FOR POTENTIAL SUBCUTANEOUS HEMOPHILIA THERAPY AND FINAL PHASE I DATA ON RECOMBINANT VON WILLEBRAND FACTOR

July 26, 2011

FOR IMMEDIATE RELEASE Media Contacts Doreen Eaton, (805) 372-3417 Marie Kennedy, (805) 372-3543 Investor Contacts Mary Kay Ladone, (847) 948-3371 Clare Trachtman, (847) 948-3085 BAXTER PRESENTS PRECLINICAL DATA AT ISTH ON ITS INVESTIGATIONAL COMPOUND BAX 499 FOR POTENTIAL SUBCUTANEOUS HEMOPHILIA THERAPY AND FINAL PHASE I DATA ON RECOMBINANT VON WILLEBRAND FACTOR Three Baxter Scientists Granted […]

CSL Behring Donates von Willebrand Factor / Factor VIII Donation to World Federation of Hemophilia

July 21, 2011

Link to news release Company gives more than 1 million units of VWD medication via WFH’s Global Alliance for Progress program as part of its 3-year commitment to the organization King of Prussia, PA 鈥 18 July 2011 CSL Behring has donated more than 1 million international units (IU) of von Willebrand factor (VWF)/Factor VIII […]

KOGENATE庐 FS, ANTIHEMOPHILIC FACTOR (RECOMBINANT), FOR HEMOPHILIA A NOW EASIER FOR PEOPLE TO STORE AT HOME OR ON THE GO

June 13, 2011

Click for link to article WAYNE, NJ, April 25, 2011 – Bayer HealthCare Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved a new storage option for Kogenate® FS, antihemophilic factor (recombinant), now allowing the product to be stored at room temperature (up to 77掳 F) for up to one year. […]

BioRx Is Fast 55 Award Finalist

April 25, 2011

News Release 聽(Cincinnati, Ohio)聽 April 25, 2011聽聽 The Cincinnati Business Courier announces that BioRx is again a finalist, for the third consecutive year, in its Fast 55 Award Program.聽 Currently listed in the $50.1 to $199 million category, BioRx also won a Fast 55 Award in 2008 and 2009.聽 The Business Courier moved the 2010 […]

Novo Nordisk Annals Letter to the Editor

April 19, 2011

Novo Nordisk Annals Letter to the Editor

Biogen Idec Celebrates World Hemophilia Day

April 19, 2011

April 15, 2011 Dear members of the bleeding disorders community, On Sunday, alongside individuals with bleeding disorders and their families, advocates and healthcare professionals, Biogen Idec celebrates World Hemophilia Day and reinforces our strong commitment to scientific discovery focused on changing the lives of people with hemophilia. While hemophilia is a new disease area for […]

Drug That Slows Bleeding Shows Off-Label Dangers

April 19, 2011

Link to New your Times Article By GINA KOLATA Published: April 18, 2011 A powerful, costly drug approved in 1999 for a small group of patients who may bleed uncontrollably during surgery is now used in a host of other surgical situations, sometimes with serious negative effects, two new studies report. The studies present a […]

H&P Industries, Inc. Issues a Voluntary Nationwide Recall of All Lots of POVIDINE PREP PADS

March 21, 2011

Contact: Customer Service 262-538-2900 FOR IMMEDIATE RELEASE 鈥 March 15, 2011 鈥擧artland, Wisconsin, H&P industries, Inc.,聽a manufacturer of over-the-counter products has initiated a voluntary product recall of ALL LOTS of POVIDINE PREP PADS manufactured by H&P Industries, Inc. but which are private labeled for many accounts.聽This recall has been initiated due to results of the […]

Grifols Alphanate vCJD Labeling Press Release

March 4, 2011

FOR IMMEDIATE RELEASE FDA Approves Revised Alphanate® Labeling to Include Reduced Infectivity of an Experimental Model Agent for vCJD Alphanate® is the first plasma-derived blood clotting factor to include labeling statements on manufacturing processes that provide a reasonable assurance of removal for low levels of a variant Creutzfeldt-Jakob disease (vCJD) model agent. Barcelona, Spain (March […]

Bayer Hemophilia Leadership Development Program

February 3, 2011

Apply for the Bayer Hemophilia Leadership Development Program today. It’s your chance to participate in a summer internship that will help develop the skills needed to be a successful leader. Take this opportunity to ask questions, learn from business professionals, develop key relationships, prepare for real-world transitions after college, and more importantly, have FUN! Deadline […]

Pfizer Inc. And Progenics Alert Physicians And Patients To Information Related To Triad Group Alcohol Prep Products Included In U.S. RELISTOR Kit Packaging Wed, 26 Jan 2011 10:53:00 -0600 NEW YORK, N.Y. and TARRYTOWN, N.Y.

January 26, 2011

Pfizer Inc. and Progenics Pharmaceuticals, Inc. have learned of a United States market recall of alcohol prep pads and swabs manufactured by the Triad Group. In the interest of patient safety, Pfizer and Progenics are alerting U.S. patients and physicians to Triad’s recall.

News Release BioRx Announces New Chief Financial Officer

January 10, 2011

January 10, 2011 (Cincinnati, Ohio)聽 BioRx announced it has hired Robin R. Johnson, MBA, CPA, as its new Chief Financial Officer. Johnson comes to BioRx from Vohra Health Services of Miami, Florida, the nation’s largest wound care provider, where she served as Interim Chief Financial Officer. At BioRx, Johnson’s responsibilities are to plan, implement, and […]

Important Information for the Hemophilia Community Regarding Triad Group’s Alcohol Prep Products and Bayer’s BayCuffTM and First Aid Kit

January 10, 2011

Click here to letter from Bayer January 10, 2011 Dear Bayer Customer: Bayer HealthCare Pharmaceuticals has become aware of a broad United States market recall of alcohol prep pads, swabs and swabsticks manufactured by the Triad Group and marketed under various brand names. In the interest of patient safety, Bayer wants to ensure that you […]

RECALL: Triad Group Issues a Voluntary Nationwide Recall of All Lots of Alcohol Prep Pads, Alcohol Swabs, and Alcohol Swabsticks Due to Potential Microbial Contamination

January 7, 2011

Article Link Contact: Eric Haertle, COO 262-538-2900 FOR IMMEDIATE RELEASE – January 5, 2011 – Hartland, Wisconsin, Triad Group, a manufacturer of over-the-counter products has initiated a voluntary product recall involving ALL LOTS of ALCOHOL PREP PADS, ALCOHOL SWABS, and ALCOHOL SWABSTICKS manufactured by Triad Group but which are private labeled for many accounts to […]

Biogen Idec Press Release: Biogen Idec and Swedish Orphan Biovitrum Announce First Patient Dosed in Global Registrational Trial of Long-Lasting Recombinant Factor VIII Fc Fusion Protein

December 7, 2010

Click here for press release First Long-Lasting Factor VIII Candidate in Late-Stage Clinical Trial for Treatment of Hemophilia A WESTON, Mass. & STOCKHOLM, Dec 06, 2010 (BUSINESS WIRE) — Biogen Idec (NASDAQ: BIIB) and Swedish Orphan Biovitrum (STO: SOBI) today announced that the first patient has been dosed with the companies’ long-lasting recombinant Factor VIII […]

CSL Behring Announces Availability of Next Generation HeliTrax庐 System for People with Hemophilia A

December 1, 2010

聽Custom software platform is first internet-enabled mobile application to interface directly with patient management systems used by hemophilia treatment centers 聽 KING OF PRUSSIA, Pa., Dec. 1, 2010 /PRNewswire/ — CSL Behring announced today the availability of the next generation HeliTrax® System as part of a specially designed software platform for Apple’s iPhone®, iPod touch®, […]

BioRx Offers Free 2010 Kids Hemophilia Calendar

November 24, 2010

Link to article November 9, 2009 (Cincinnati, Ohio) – BioRx, a specialty pharmaceutical company, announces the availability of a free 2010 calendar to the hemophilia community. The annual BioRx Kids Hemophilia Calendar features artwork from children who either have a bleeding disorder or have a sibling or parent with a bleeding disorder. To produce the […]

BioRx Offers Scholarships to Bleeding Disorders Community

November 24, 2010

Link to article September 1, 2010 (Cincinnati, Ohio) BioRx and Hemophilia of North Carolina announce the availability of four 2011 BioRx Educational Scholarships in the amount of $2,000 each to individuals with bleeding disorders. The scholarships will be awarded for the 2011-2012 school year, and the deadline for submitting applications is May 1, 2011. BioRx […]

Novo Nordisk announced the U.S. Food and Drug Administration (FDA) has approved NovoSeven庐 RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) in an 8 mg vial size.

September 2, 2010

Novo Nordisk announced聽on August 10聽that the U.S. Food and Drug Administration (FDA) has approved NovoSeven® RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) in an 8 mg vial size, making the hemophilia A or B with inhibitors treatment available in 1, 2, 5 and 8 mg vials. The 8 mg vial allows a rapid initiation […]

Novo Nordisk provides a development update on two new investigational drugs for the bleeding disorders community.

August 30, 2010

The company’s ultra fastacting recombinant factor VIIa is progressing to a phase 3 trial after the successful completion of a phase 2 safety, pharmacokinetics and efficacy trial; the phase 3 trial is currently being designed.聽 A phase 3 trial for the factor XIII drug was recently been completed and showed that, compared to a historic […]

Pfizer Receives FDA Approval for Prefilled Dual-Chamber Syringe for Use in the Treatment of Hemophilia A

August 9, 2010

Pfizer Press Release Pfizer is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted approval for the use of a Prefilled Dual-Chamber Syringe for administration of XYNTHA® Antihemophilic Factor (Recombinant) Plasma/Albumin-Free to hemophilia A patients. XYNTHA is an injectable recombinant factor VIII product previously approved by the FDA for both the […]

BioRx President Phil Rielly Wins Ernst & Young Entrepreneur of the Year庐 Award

July 28, 2010

(Cincinnati, Ohio)聽 July 20, 2010 – Philip Rielly, President and Co-founder of specialty pharmacy BioRx LLC, 聽has received the Ernst & Young Entrepreneur Of The Year® 2010 Award in the Healthcare category in South 聽Central Ohio and Kentucky.聽 According to Ernst & Young LLP, the award recognizes outstanding entrepreneurs 聽who are building and leading dynamic, […]

Winners announced for 2010 BioRx Educational Scholarships

July 21, 2010

News Release聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽 June 21, 2010 (Cincinnati, Ohio)聽聽 BioRx, a specialty pharmacy, and Hemophilia of North Carolina, a non-profit organization that assists and educates persons affected by bleeding disorders, announce the winners of the 2010 BioRx Educational Scholarships.聽 Each of the winners receives a $2,000 scholarship.聽 The scholarships are funded by BioRx through an educational grant, […]


Sign up for E-mails, Dateline Magazine, and other ways to stay connected.